Personal ‘omics profiling
R. Chen (Stanford, USA)
|  |
Severe asthma
P. Sterk (Amsterdam, The Netherlands)
|  |
miR-17 and -21 in intercellular communication via exosomes in allergic airway inflammation
S. Bartel (Borstel, Germany)
| |
Eicosanoids in asthma: multi-omics data interpretation
A. Mazein (Lyon, France)
| |
COPD
R. Faner (Barcelona, Spain)
|   |
Single cell ‘omics analysis
Y. Xu (Cincinnati, USA)
| |
Non-canonical WNT signaling is mediated by extracellular vesicles in pulmonary fibrosis
A. Martin (Munich, Germany)
| |
Vitamin D stimulates macrophage efferocytosis and encourages a proresolution phenotype
D. Parekh (Birmingham, United Kingdom)
| |
Building handprints of complex diseases: the U-BIOPRED case
B. De Meulder (Lyon, France)
| |
RibomiR-seq reveals microRNAs fine-tune the transcriptome but profoundly alter translation in severe asthma
R. Martinez-Nunez (Southampton, United Kingdom)
| |
The association between fine ambient particulate air pollution and lung cancer incidence in adventist health and smog -2 (AHSMOG-2) cohort study
L. Gharibvand (Loma Linda, United States of America)
| |
An integrated approach to the exposome
V. Siroux (Grenoble, France)
| |
Poster Session 1
A. Francisco-Garcia (Southampton, United Kingdom), C. Simillion (Bern, Switzerland), K. Förster (Munich, Germany), A. Ravi (Amsterdam, Netherland), I. Osinska (Warsaw, Poland), D. Dvornikov (Heidelberg, Germany), L. Plantier (Paris, France), R. Dancer (Birmingham, United Kingdom), S.G. Ocal (Ankara, Turkey), A. Petrovic (Giessen, Germany), S. Pastor (Valencia, Spain), R. Hendrix (Saarbrucken, Germany), A. Marazioti (Patras, Greece), N. Rocks (Liège, Belgium), M. Eapen (Hobart, Australia), A. Menou (Paris, France), K. Roach (Leicester, United Kingdom), J.D.S. Domingues (Toulouse, France), A. Chatziantoniou (Heraklion, Greece), J. Parker (London, United Kingdom), I. Janulaityte (Kaunas, Lithuania), E. Gamen (Bad Nauheim, Germany), A. Fedorowicz (Krakow, Poland), R. Zinsky (Germany, Wiesbaden), C.-X. Li (Stockholm, Sweden), E. De Smet (Ghent, Belgium), M. Szczygiel (Heidelberg, Germany), M.E. Quesada del Bosque (Southampton, United Kingdom), E. Papakonstantinou (Basel, Switzerland), A. Faiz (Groningen, Netherlands), K. Barth (Dresden, Germany), J. Brealey (Brisbane, Australia), G. Noell (Madrid, Spain), M. Vreka (Munich, Germany), M. Zorzetto (Pavia, Italy), P.J. McKiernan (Dublin, Ireland), A. Houssaini (Munich, Germany)
| |
New tools for epidemiological medical research in the digital age
M. Salathé (Genève, Switzerland)
| |
Natural experiments and large databases in Respiratory, CVD and tobacco control
J. Vestbo (Manchester, United Kingdom)
| |
Systemic and local metabolomics profiling reveals novel insights into the progression of emphysema
T. Conlon (Munich, Germany)
| |
Alpha8 integrin deficiency alters branching morphogenesis and alveolarization during mouse lung development
T.P. Cremona (Bern, Switzerland)
| |
Modelling the whole lung
J. Bates (Burlington, USA)
| |
Epigenome-wide mapping of histone modification landscape in human pulmonary arterial hypertension
P. Chelladurai (Bad Nauheim, Germany)
| |
Transcriptomic profiling of Macrophages isolated from human Non-Small Cell Lung Carcinoma (NSCLC) reveals novel Macrophage subsets with distinct tumour response features
E.M. Garrido-Martin (Southampton, United Kingdom)
| |
Peripheral blood myeloid-derived suppressor cells reflect disease status in IPF
I.E. Fernandez (Munich, Germany)
| |
Identifying biomarkers of loss of control/exacerbations in asthma from exhaled breath
S. Anirban (Amsterdam, Netherlands)
| |
The use of microarray analysis of gene signalling to determine heterogeneity of COPD exacerbation phenotypes
K. Bolger (Dublin, Ireland)
| |
Poster Session 2
N. Moyo (Liverpool, United Kingdom), C. Prele (Perth, Australia), G. Conickx (Ghent, Belgium), A. Mazein (Lyon, France), M. Klös (Leipzig, Germany), J. Tilman (London, United Kingdom), L. Gouveia (Uppsala, Sweden), P. Oak (Munich, Germany), J.D. Santos (Lisbon, Portugal), L. Bos (Amsterdam, Netherlands), H. Hou (Taipei, Taiwan), O. Burgy (Dijon, France), A. Singhania (Southampton, United Kingdom), P. Oak (Munich, Gemany), S. Tebbutt (Vancouver, Canada), M. Spella (Patras, Greece), F. Milla (London, United Kingdom), M. Zorzetto (Pavia, Italy), M. Eapen (Hobart, Australia), L.C. Hall (Madrid, Spain), M. Nakhleh (Le Plessis Robinson, France), A. Januskevicius (Kaunas, Lithuania), K. Reiss (Aachen, Germany), A. Durham (London, United Kingdom), A. Reula (Valencia, Spain), I. Osinska (Warsaw, Poland), S. Lax (Birmingham, United Kingdom), J. Mandal (Basel, Switzerland), I. Psallidas (Oxford, United Kingdom), R. Costa (Munich, Germany), A. Joannes (Paris, France), J. Upham (Brisbane, Australia), Y. Shari Pineros Sabogal (Amsterdam, Netherlands), E. Ringqvist (Stockholm, Sweden), L. Lahousse (Ghent, Belgium), D. Parekh (Birmingham, United Kingdom)
| |
Metabolomics for molecular phenotyping in respiratory disease
C. Wheelock (Stockholm, Sweden)
| |
ILD and system medicine
O. Eickelberg (Munich, Germany)
| |
Systems pharmacology
L. Edwards (Stevenage, United Kingdom)
| |